These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 16457646)

  • 1. Gene therapy for pituitary tumors.
    Seilicovich A; Pisera D; Sciascia SA; Candolfi M; Puntel M; Xiong W; Jaita G; Castro MG
    Curr Gene Ther; 2005 Dec; 5(6):559-72. PubMed ID: 16457646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for pituitary tumors: from preclinical models to clinical implementation.
    Castro M; Goverdhana S; Hu J; Jovel N; Yuan X; Lowenstein P
    Front Neuroendocrinol; 2003 Jan; 24(1):62-77. PubMed ID: 12609500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted expression of toxic genes directed by pituitary hormone promoters: a potential strategy for adenovirus-mediated gene therapy of pituitary tumors.
    Lee EJ; Anderson LM; Thimmapaya B; Jameson JL
    J Clin Endocrinol Metab; 1999 Feb; 84(2):786-94. PubMed ID: 10022454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy strategies for intracranial tumours: glioma and pituitary adenomas.
    Castro MG; Cowen R; Smith-Arica J; Williams J; Ali S; Windeatt S; Gonzalez-Nicolini V; Maleniak T; Lowenstein PR
    Histol Histopathol; 2000 Oct; 15(4):1233-52. PubMed ID: 11005248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy of pituitary diseases.
    Lee EJ; Jameson JL
    J Endocrinol; 2005 Jun; 185(3):353-62. PubMed ID: 15930161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular therapy in a model neuroendocrine disease: developing clinical gene therapy for pituitary tumours.
    Castro MG; Southgate T; Lowenstein PR
    Trends Endocrinol Metab; 2001 Mar; 12(2):58-64. PubMed ID: 11167123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral vectors efficiently transduce human gonadotroph and somatotroph adenomas in vitro. Targeted expression of transgene by pituitary hormone promoters.
    Roche C; Zamora AJ; Taïeb D; Lavaque E; Rasolonjanahary R; Dufour H; Bagnis C; Enjalbert A; Barlier A
    J Endocrinol; 2004 Oct; 183(1):217-33. PubMed ID: 15525589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cells.
    Roche C; Rasolonjanahary R; Thirion S; Goddard I; Fusco A; Figarella-Branger D; Dufour H; Brue T; Franc JL; Enjalbert A; Barlier A
    Hum Gene Ther; 2012 Jan; 23(1):104-14. PubMed ID: 21942649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic injection of adenoviral vectors that target gene expression to specific pituitary cell types: implications for gene therapy.
    Lee EJ; Thimmapaya B; Jameson JL
    Neurosurgery; 2000 Jun; 46(6):1461-8; discussion 1468-9. PubMed ID: 10834649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of gene therapy for the treatment of pituitary tumors.
    Goya RG; Sarkar DK; Brown OA; Hereñú CB
    Curr Gene Ther; 2004 Mar; 4(1):79-87. PubMed ID: 15032616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous and medically induced cerebrospinal fluid leakage in the setting of pituitary adenomas: review of the literature.
    Lam G; Mehta V; Zada G
    Neurosurg Focus; 2012 Jun; 32(6):E2. PubMed ID: 22655691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant pituitary adenoma: histological types, clinical features and therapeutic approaches.
    Iglesias P; Rodríguez Berrocal V; Díez JJ
    Endocrine; 2018 Sep; 61(3):407-421. PubMed ID: 29909598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of pituitary tumors.
    Shimon I; Melmed S
    Ann Intern Med; 1998 Sep; 129(6):472-83. PubMed ID: 9735086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary issues in the evaluation and management of pituitary adenomas.
    Pekic S; Stojanovic M; Popovic V
    Minerva Endocrinol; 2015 Dec; 40(4):307-19. PubMed ID: 25900682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary tumors secreting growth hormone and prolactin.
    Melmed S; Braunstein GD; Chang RJ; Becker DP
    Ann Intern Med; 1986 Aug; 105(2):238-53. PubMed ID: 3524338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of pediatric sellar tumors.
    Jane JA
    Pediatr Endocrinol Rev; 2008 Feb; 5 Suppl 2():720-6. PubMed ID: 18317443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic implications of accurate classification of pituitary adenomas.
    Mete O; Asa SL
    Semin Diagn Pathol; 2013 Aug; 30(3):158-64. PubMed ID: 24144285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary tumors: pathophysiology, clinical manifestations and management.
    Arafah BM; Nasrallah MP
    Endocr Relat Cancer; 2001 Dec; 8(4):287-305. PubMed ID: 11733226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.